Cholestasis: How ALP, GGT, and Bile Acids Flag Blocked Flow

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Cholestasis is detected in blood through four markers—ALP (typically 30–120 U/L), GGT (10–60 U/L), direct bilirubin (0–0.3 mg/dL), and bile acid ratio (BAR, commonly under 10)—that may help support assessment of backed-up bile flow before complications develop. When these markers rise together, they are associated with jaundice, dark urine, pale stools, and itching, guiding timely imaging and monitoring of fat-soluble vitamin absorption and pregnancy outcomes.

Read more →

Understand what your liver function testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Cholestasis: When bile flow stalls

Cholestasis biomarkers are blood signals that show how well bile is being made and moved out of the liver. They reflect the backup of bile and the stress it puts on liver cells and the tiny ducts that carry bile. When bile flow slows or is blocked, components of bile spill into the bloodstream and duct-lining enzymes leak from their membranes. The key signals come from bile pigments and acids (conjugated bilirubin, bile acids) and from enzymes concentrated in bile duct cells (alkaline phosphatase and gamma-glutamyl transferase, plus 5′-nucleotidase). Together, they let clinicians confirm that the problem is impaired bile flow rather than primary injury to liver cells, hint at where the blockage or dysfunction lies (inside the liver versus in the larger ducts), and track whether bile flow is improving with time or treatment. In short, cholestasis biomarkers turn an invisible traffic jam of bile into measurable clues that guide imaging, diagnosis, and safe use of medications that depend on bile excretion.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why a cholestasis pattern deserves quick interpretation

Cholestasis tests show how well your liver makes and moves bile—the detergent that clears bilirubin, carries bile acids, and absorbs dietary fats. When bile backs up, these molecules rise in blood and ripple across systems: skin and nerves, digestion, hormones, and pregnancy outcomes. ALP is typically about 30–120, with healthy adults in the middle; adolescents and pregnancy run higher. GGT is roughly 10–60 and tends toward the lower half. Direct bilirubin sits near 0–0.3, ideally close to zero. BAR is commonly under about 10 and lowest with normal flow. When ALP and GGT rise together—along with direct bilirubin and BAR—it points to cholestasis: itching, dark urine, pale stools, jaundice, and greasy stools. In pregnancy, elevated bile acids track with pruritus and greater fetal risk even when other tests are mild. Lower readings mean different things. Very low ALP reflects reduced bone/liver isoenzyme activity, rarely from hypophosphatasia or severe malnutrition; low GGT is usually not clinically important. Direct bilirubin near zero is normal. Low BAR is expected outside pregnancy; unusually low bile acids suggest rare synthesis defects or very low fat intake. Together these markers map bile formation, canalicular transport, and downstream fat and vitamin handling. Persistent cholestatic patterns tie to fat‑soluble vitamin deficiency, bone loss, gallstones, pancreatitis, and chronic liver disease. Viewed with ALT/AST, albumin, platelets, and imaging, they clarify cause and forecast long‑term liver and metabolic risks.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

What a cholestasis panel can and can't resolve

Cholestasis blood testing provides insight into how well your liver and biliary system are moving bile, a fluid essential for digesting fats and removing waste from the body. When bile flow is disrupted, it can affect energy production, metabolism, hormone balance, and immune function. At Superpower, we assess cholestasis using four key biomarkers: alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), direct (conjugated) bilirubin, and the bilirubin/alkaline phosphatase ratio (BAR). ALP is an enzyme found in the cells lining the bile ducts. GGT is another enzyme that rises when there is stress or blockage in the bile pathways. Direct bilirubin measures the form of bilirubin that has been processed by the liver and is ready for excretion in bile. The BAR helps distinguish between different patterns of liver and bile duct involvement. Together, these markers reveal how efficiently bile is being produced and transported. Stable, healthy levels suggest that the liver and biliary system are functioning smoothly, supporting digestion, detoxification, and metabolic stability. When these markers are elevated or out of balance, it may indicate impaired bile flow, which can disrupt nutrient absorption and waste removal, and signal stress on the liver or bile ducts. Interpretation of cholestasis markers can be influenced by factors such as age, pregnancy, recent illness, certain medications, and laboratory methods. These variables should be considered when evaluating results to ensure an accurate understanding of liver and biliary health.

Frequently Asked Questions

References

  1. Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. *The New England Journal of Medicine*, *340*(6), 448-454. https://doi.org/10.1056/nejm199902113400607
  2. Xing M, Gao M, Li J, Han P, Mei L, Zhao L (2022). Characteristics of peripheral blood gamma-glutamyl transferase in different liver diseases. *Medicine*, *101*(1), e28443. https://doi.org/10.1097/md.0000000000028443
  3. Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiu MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, ... Williamson C (2019). Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. *Lancet*, *393*(10174), 899-909. https://doi.org/10.1016/s0140-6736(18)31877-4
  4. Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG (2019). Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. *Lancet*, *394*(10201), 849-860. https://doi.org/10.1016/s0140-6736(19)31270-x
  5. Tapper EB, Parikh ND (2023). Diagnosis and management of cirrhosis and its complications: a review. *JAMA*, *329*(18), 1589-1602. https://doi.org/10.1001/jama.2023.5997

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$349

/year*

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.96 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/what-we-test.